DT Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.97M | Sell |
1,645
-16
| -1% | -$16.3K | 0.15% | 65 |
|
|
2026
Q1 | $1.53M | Sell |
1,661
-7
| -0.4% | -$7.1K | 0.13% | 70 |
|
|
2025
Q4 | $1.79M | Buy |
1,668
+68
| +4% | +$65K | 0.15% | 64 |
|
|
2025
Q3 | $1.22M | Buy |
1,600
+838
| +110% | +$624K | 0.1% | 77 |
|
|
2025
Q2 | $594K | Hold |
762
| – | – | 0.05% | 103 |
|
|
2025
Q1 | $629K | Hold |
762
| – | – | 0.06% | 105 |
|
|
2024
Q4 | $588K | Buy |
762
+17
| +2% | +$14.1K | 0.05% | 106 |
|
|
2024
Q3 | $660K | Buy |
745
+75
| +11% | +$67.4K | 0.05% | 105 |
|
|
2024
Q2 | $607K | Buy |
670
+16
| +2% | +$12.8K | 0.05% | 102 |
|
|
2024
Q1 | $509K | Hold |
654
| – | – | 0.05% | 99 |
|
|
2023
Q4 | $422K | Buy |
654
+32
| +5% | +$18.7K | 0.05% | 103 |
|
|
2023
Q3 | $334K | Hold |
622
| – | – | 0.04% | 102 |
|
|
2023
Q2 | $282K | Buy |
622
+11
| +2% | +$4.61K | 0.03% | 116 |
|
|
2023
Q1 | $248K | Buy |
611
+400
| +190% | +$135K | 0.03% | 116 |
|
|
2022
Q4 | $77.2K | Hold |
211
| – | – | 0.01% | 180 |
|
|
2022
Q3 | $68K | Buy |
+211
| New | +$66.9K | 0.01% | 182 |
|
|
2017
Q3 | – | Sell |
-19,656
| Closed | -$1.62M | – | 89 |
|
|
2017
Q2 | $1.62M | Buy |
19,656
+2,930
| +18% | +$239K | 0.31% | 30 |
|
|
2017
Q1 | $1.41M | Buy |
16,726
+2,467
| +17% | +$198K | 0.32% | 28 |
|
|
2016
Q4 | $1.05M | Buy |
14,259
+872
| +7% | +$64.9K | 0.27% | 37 |
|
|
2016
Q3 | $1.07M | Buy |
13,387
+667
| +5% | +$53.4K | 0.28% | 29 |
|
|
2016
Q2 | $1M | Buy |
12,720
+2,271
| +22% | +$171K | 0.27% | 32 |
|
|
2016
Q1 | $752K | Sell |
10,449
-433
| -4% | -$32.8K | 0.21% | 40 |
|
|
2015
Q4 | $917K | Buy |
10,882
+61
| +0.6% | +$5.06K | 0.27% | 25 |
|
|
2015
Q3 | $906K | Sell |
10,821
-1,023
| -9% | -$86.4K | 0.28% | 22 |
|
|
2015
Q2 | $988K | Buy |
11,844
+222
| +2% | +$16.9K | 0.26% | 36 |
|
|
2015
Q1 | $844K | Buy |
11,622
+403
| +4% | +$28.7K | 0.26% | 30 |
|
|
2014
Q4 | $774K | Buy |
11,219
+146
| +1% | +$9.86K | 0.24% | 34 |
|
|
2014
Q3 | $718K | Buy |
11,073
+1,068
| +11% | +$67.6K | 0.23% | 36 |
|
|
2014
Q2 | $622K | Buy |
10,005
+1,194
| +14% | +$71.2K | 0.21% | 37 |
|
|
2014
Q1 | $519K | Buy |
8,811
+55
| +0.6% | +$3.07K | 0.21% | 39 |
|
|
2013
Q4 | $447K | Buy |
8,756
+327
| +4% | +$16.4K | 0.18% | 46 |
|
|
2013
Q3 | $424K | Buy |
8,429
+804
| +11% | +$42.1K | 0.17% | 43 |
|
|
2013
Q2 | $375K | Buy |
+7,625
| New | +$415K | 0.18% | 39 |
|
Other funds holding LLY
SC
DT Investment Partners's LLY Position: Q2 2026 in Review
DT Investment Partners reduced its Eli Lilly (LLY) stake by 0.96% in Q2 2026, selling an estimated $16.3K and leaving 1,645 shares worth $1.97M. The position accounts for 0.15% of the portfolio, ranked #65.
DT Investment Partners first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. 2,260 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- DT Investment Partners held 1,645 shares of Eli Lilly worth $1.97M as of Q2 2026.
- DT Investment Partners sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
- Eli Lilly made up 0.15% of DT Investment Partners's portfolio in Q2 2026, its #65 holding.
- DT Investment Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
- 2,260 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.